Tata India Pharma & Healthcare Fund-Direct Plan-Growth
Fund House: Tata Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 28-12-2015 |
| Asset Class: Equity |
| Benchmark: NIFTY Pharma TRI |
| TER: 0.62% As on (30-06-2025) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 1,231.72 Cr As on 30-05-2025(Source:AMFI) |
| Turn over: 22.57% | Exit Load: 0.25% of NAV if redeemed /switched out before 30 days from the date of allotment. |
35.8729
0.45 (1.265%)
14.27%
Benchmark: 14.57%
PERFORMANCE
Returns Type:
of :
Start :
End :
Period:
This Scheme
-
vs
NIFTY Pharma TRI
-
Gold
-
PPF
-
Returns Type:
of :
Period:
Start :
Period:
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Time Taken To Multiply
2x
4x
5x
10x
FUND
5 Years 8 Months
There is no value for 4x
There is no value for 5x
There is no value for 10x
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 16.0 |
| Sharpe Ratio | 1.24 |
| Alpha | 4.91 |
| Beta | 0.94 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
31.98%
Others
7.69%
Large Cap
27.58%
Mid Cap
32.75%
